The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Initial routes focused on peptide portion coupling, utilizing solid-phase https://margienmzc697583.blogpayz.com/40991359/synthesis-and-investigation-implementations-of-retatrutide